v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 288,193 $ 307,531
Prepaid expenses and other current assets 3,820 7,662
Total current assets 292,013 315,193
Non-current assets:    
Property and equipment, net 2,486 2,144
Operating lease right-of-use assets 6,738 8,125
Restricted cash, non-current 860 860
Other non-current assets 482 482
Total non-current assets 10,566 11,611
Total assets 302,579 326,804
Current liabilities:    
Accounts payable 1,941 5,875
Accrued research and development 550 4,329
Deferred revenue, current 620 2,664
Restructuring liability 349 13,303
Lease liability, current 2,961 2,886
Other current liabilities 5,237 11,786
Total current liabilities 11,658 40,843
Non-current liabilities:    
Lease liability, non-current 4,030 5,487
Total non-current liabilities 4,030 5,487
Total liabilities 15,688 46,330
Commitments and contingencies (Note 6)
Shareholders’ equity:    
Euro deferred shares, €22 nominal value: Authorized shares — 10,000 at June 30, 2026 and December 31, 2025 and Issued and outstanding shares — none at June 30, 2026 and December 31, 2025 0 0
Ordinary shares, $0.01 par value: Authorized shares — 100,000,000 at June 30, 2026 and December 31, 2025 and Issued and outstanding shares — 51,744,327 and 53,832,982 at June 30, 2026 and December 31, 2025, respectively 517 538
Additional paid-in capital 1,618,669 1,626,369
Accumulated deficit (1,332,295) (1,346,433)
Total shareholders’ equity 286,891 280,474
Total liabilities and shareholders’ equity $ 302,579 $ 326,804